Literature DB >> 173184

Human erythrocyte galactokinase and galactose-1-phosphate uridylyltransferase: a population survey.

T A Tedesco, K L Miller, B E Rawnsley, M T Mennuti, R S Spielman, W J Mellman.   

Abstract

Erythrocyte (RBC) galactokinase (GALK) and galactose-1-phosphate uridylyl-transferase (GALT) activities were measured in a random sample of 1,700 (1.082 black and 618 white) pregnant women from the Philadelphia area to estimate the frequency of the genes GALKG and GALTG responsible for the two biochemically distinct forms of galactosemia. Blacks have significantly lower mean RBC GALK activities than whites (P less than .0005). The distribution of individual GALK activities for blacks differs from a normal distribution (X227=43.0, P less than .03) whereas that for whites does not (X224=25.5, P approximately equal to .30). These results are consistent with the thesis that reduced RBC GALK activity in blacks is due to the Philadelphia variant (GALKP), which is common in blacks and rare in whites. The frequency of heterozygotes (GALKG/GALKA, GALKG/GALKP) for GALK galactosemia observed in this sample is 1/340 for the total, 1/347 for blacks, and 1/309 for whites. The existence of the GALKP variant allele has been considered in this determination. However, because a method for distinguishing the GALKP and GALKG alleles became available only in the latter part of the study, the frequency of the GALK G allele in the black population may be underestimated. The mean RBC GALT activity for blacks is higher than that for whites, a difference that may be due to a higher frequency of the Duarte variant allele GALTD in whites. Heterozygotes (GALTG/GALTA) for GALT galactosemia were distinguished by family studies and starch gel electrophoresis from individuals who have half-normal RBC GALT activity due to the GALTD allele. The GALTG/GALTA frequency is 1/212 for the total, 1/217 for blacks, and 1/206 for whites. Of the 1,700 individuals surveyed three had atypically high RBC GALK activity, similar to that found in red blood cells of newborns.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 173184      PMCID: PMC1762902     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  17 in total

1.  ESTIMATION OF FREQUENCY OF OCCURRENCE OF GALACTOSEMIA IN THE POPULATION.

Authors:  R G HANSEN; R K BRETTHAUER; J MAYES; J H NORDIN
Journal:  Proc Soc Exp Biol Med       Date:  1964-02

2.  A study of the genetics of galactosaemia.

Authors:  V SCHWARZ; A R WELLS; A HOLZEL; G M KOMROWER
Journal:  Ann Hum Genet       Date:  1961-12       Impact factor: 1.670

3.  Experience of routine live-birth screening for galactosaemia in a British hospital, with emphasis on heterozygote detection.

Authors:  G Ellis; A R Wilcock; D M Goldberg
Journal:  Arch Dis Child       Date:  1972-02       Impact factor: 3.791

4.  Galactosemia screening of newborns in Massachusetts.

Authors:  V E Shih; H I Levy; V Karolkewicz; S Houghton; M L Efron; K J Isselbacher; E Beutler; R A MacCready
Journal:  N Engl J Med       Date:  1971-04-08       Impact factor: 91.245

5.  [Gene frequency of hereditary galactosemia with reference to the Duarte variant].

Authors:  H Kaloud; F C Sitzmann
Journal:  Z Kinderheilkd       Date:  1972

6.  A new variant of galactose-1-phosphate uridyltransferase in man: the Los Angeles variant.

Authors:  W G Bergren; G N Donnell
Journal:  Ann Hum Genet       Date:  1973-07       Impact factor: 1.670

7.  [Galactosemia, generally with a fulminating course. 10 cases found through an early detection program].

Authors:  S Scheibenreiter; O Thalhammer
Journal:  Wien Klin Wochenschr       Date:  1972-02-11       Impact factor: 1.704

8.  Galactokinase deficiency: clinical and biochemical findings in a new kindred.

Authors:  W R Pickering; R R Howell
Journal:  J Pediatr       Date:  1972-07       Impact factor: 4.406

9.  Screening for galactosemia. Studies of the gene frequencies for galactosemia and the Duarte variant.

Authors:  E Beutler
Journal:  Isr J Med Sci       Date:  1973 Sep-Oct

10.  Screening for galactosemia in New York State.

Authors:  S Kelly; S Katz; J Burns; J Boylan
Journal:  Public Health Rep       Date:  1970-07       Impact factor: 2.792

View more
  5 in total

1.  Dissection of a continuous distribution: red cell galactokinase activity in blacks.

Authors:  R S Spielman; H Harris; W J Melliman; H Gershowitz
Journal:  Am J Hum Genet       Date:  1978-05       Impact factor: 11.025

2.  Variants of galactose-1-phosphate uridyl transferase in the Greek populations.

Authors:  A Thomakos; E Beutler; G Stamatoyannopoulos
Journal:  Hum Genet       Date:  1977-05-10       Impact factor: 4.132

3.  Galactose tolerance studies of individuals with reduced galactose pathway activity.

Authors:  W J Mellman; B E Rawnsley; C W Nichols; B Needelman; M T Mennuti; J Malone; T A Tedesco
Journal:  Am J Hum Genet       Date:  1975-11       Impact factor: 11.025

4.  The Philadelphia variant of galactokinase.

Authors:  T A Tedesco; K L Miller; B E Rawnsley; M C Adams; H B Markus; K G Orkwiszewski; W J Mellman
Journal:  Am J Hum Genet       Date:  1977-05       Impact factor: 11.025

5.  Screening of the Philadelphia variant of galactokinase in racially unmixed black Africans: first results.

Authors:  T Soni; M Brivet; M Blanc; G Jaeger; A Lemonnier
Journal:  Am J Hum Genet       Date:  1988-01       Impact factor: 11.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.